Research reference only. Not medical advice. Most compounds are not FDA-approved. These are research chemicals, not for human consumption. Consult a qualified clinician.Read methodology Terms update on 18 Dec 2026
← Back to Research Index
Compare Evaluate Matrix Half-Life
Dossier · № 49 of 110 Updated Nov 17, 2026

KPV

Lys-Pro-Val · α-MSH(11-13)

PRECLINICAL + ANECDOTAL · TRIPEPTIDE; Α-MSH-DERIVED ANTI-INFLAMMATORY

▓ 108 indexed citations across PubMed (103), EuropePMC (5).

Citation breakdown by evidence tier

← weaker evidence  ·  stronger evidence →

108 citations across 3 tiers

Tap any tier to jump to that section of the bibliography.

Background

The KPV heavy machine gun is a Soviet designed 14.5×114mm-caliber heavy machine gun, which first entered service as an infantry weapon in 1949. In the 1960s, the infantry version was taken out of production because it was too large and heavy. It was later redesigned for anti-aircraft use, as it showed excellent results as an AA gun against low flying aircraft, with a range of 3,000 m (9,800 ft) horizontally and 2,000 m (6,600 ft) vertically. It was used in the ZPU series of anti-aircraft guns. Its size and power also made it a useful light anti-armour weapon on the BTR series of vehicles and the BRDM-2 scout car.

→ Wikipedia

Mechanism of action

Inhibits NF-κB; stabilizes mast cells; reduces pro-inflammatory cytokines; mimics α-MSH C-terminus

Researched effects

Potent anti-inflammatory; mast cell stabilization; gut barrier repair; IBD/colitis benefit; skin inflammation

Live evidence

Live signals refreshed daily. Current as of November 19, 2026.

Dosing reported in literature

200 mcg daily oral or SC (anti-inflammatory starting dose for IBD and skin support, range up to 500 mcg/day per r/Peptides wiki); topical 0.1-1%

→ Brzoska T et al. KPV anti-inflammatory pharmacology (PMID 18180457); r/Peptides wiki IBD and skin dosing consensus

Known concerns

Limited human data; oral bioavailability uncertain

Top-ranked picks

10 pre-curated authoritative sources, ranked by journal tier and study weight.

  1. Alpha-melanocyte-stimulating hormone and related tripeptides: biochemistry, antiinflammatory and protective effects in vitro and in vivo, and future perspectives for the treatment of immune-mediated inflammatory diseases.

    Endocrine reviews · 2008 — REVIEWS · AUTHORITY 62.8

  2. Host defense peptides as a new drug lead to a strategy for inflammatory bowel disease.

    Drug discovery today · 2025 — REVIEWS · AUTHORITY 54.5

  3. Exploring the Role of Tripeptides in Wound Healing and Skin Regeneration: A Comprehensive Review.

    International journal of medical sciences · 2025 — REVIEWS · AUTHORITY 54.5

  4. The Melanocortin System in Inflammatory Bowel Diseases: Insights into Its Mechanisms and Therapeutic Potentials.

    Cells · 2023 — REVIEWS · AUTHORITY 54.3

  5. Terminal signal: anti-inflammatory effects of α-melanocyte-stimulating hormone related peptides beyond the pharmacophore.

    Advances in experimental medicine and biology · 2010 — REVIEWS · AUTHORITY 53.0

  6. New insights into the functions of alpha-MSH and related peptides in the immune system.

    Annals of the New York Academy of Sciences · 2003 — REVIEWS · AUTHORITY 52.3

  7. The neuroimmunomodulatory peptide alpha-MSH.

    Annals of the New York Academy of Sciences · 2000 — REVIEWS · AUTHORITY 52.0

  8. The neuropeptide alpha-MSH in host defense.

    Annals of the New York Academy of Sciences · 2000 — REVIEWS · AUTHORITY 52.0

  9. Peptide modulation of inflammatory processes within the brain.

    Neuroimmunomodulation · 1998 — REVIEWS · AUTHORITY 52.0

  10. Mechanisms of antiinflammatory action of the neuroimmunomodulatory peptide alpha-MSH.

    Annals of the New York Academy of Sciences · 1998 — REVIEWS · AUTHORITY 52.0

Full citation library

Year distribution

Reviews

10
  1. 1.

    Luger TA, Scholzen TE, Brzoska T, Böhm M · Annals of the New York Academy of Sciences · 2003 · PMID 12851308

    There is a substantial body of evidence that the tridecapeptide alpha-melanocyte-stimulating hormone (alpha-MSH) functions as a mediator of immunity and inflammation. The immunomodulating capacity of alpha-MSH is primarily because of its effects on melanocortin receptor (MC-1R)-expressing monocytes, macrophages, and dendritic cells (DCs). alpha-MSH down-regulates the production of proinflammatory and immunomodulating cytokines (IL-1, IL-6, TNF-alpha, IL-2, IFN-gamma, IL-4, IL-13) as well as the…

  2. 2.

    Brzoska T, Böhm M, Lügering A, Loser K, et al. · Advances in experimental medicine and biology · 2010 · PMID 21222263

    During the last two decades a significant number of investigations has established the fact that α-Melanocyte-stimulating hormone (α-MSH) is a potent anti-inflammatory mediator. The anti-inflammatory effects of α-MSH can be elicited via melanocortin receptors (MC-Rs) broadly expressed in a number of tissues ranging from the central nervous system to cells of the immune system and on resident somatic cells of peripheral tissues. α-MSH affects various pathways regulating inflammatory responses suc…

  3. 3.

    Ichiyama T, Sato S, Okada K, Catania A, et al. · Annals of the New York Academy of Sciences · 2000 · PMID 11268347

    Alpha-melanocyte-stimulating hormone (alpha-MSH), a neuroimmunomodulatory peptide of ancient origin, is known to be involved in the control of host responses. In inflammatory cells, in the periphery and within the central nervous system, alpha-MSH modulates the production and action of proinflammatory cytokines. This broad influence occurs via endogenous alpha-MSH (melanocortin) receptors. The key to this anti-inflammatory influence is inhibition of NF-kappa B. Indeed alpha-MSH inhibits activati…

  4. 4.

    Catania A, Cutuli M, Garofalo L, Carlin A, et al. · Annals of the New York Academy of Sciences · 2000 · PMID 11268348

    The presence of the ancient peptide alpha-melanocyte-stimulating hormone (alpha-MSH) in barrier organs such as gut and skin suggests that this potent anti-inflammatory molecule may be a component of the innate host defense. In tests of antimicrobial activities, alpha-MSH and its fragment KPV showed inhibitory influences against the gram-positive bacterium Staphylococcus aureus and the yeast Candida albicans. Anti-tumor necrosis factor and antimicrobial effects of alpha-MSH suggest that the pepti…

  5. 5.

    Brzoska T, Luger TA, Maaser C, Abels C, et al. · Endocrine reviews · 2008 · PMID 18612139

    Alpha-MSH is a tridecapeptide derived from proopiomelanocortin. Many studies over the last few years have provided evidence that alpha-MSH has potent protective and antiinflammatory effects. These effects can be elicited via centrally expressed melanocortin receptors that orchestrate descending neurogenic antiinflammatory pathways. alpha-MSH can also exert antiinflammatory and protective effects on cells of the immune system and on peripheral nonimmune cell types expressing melanocortin receptor…

  6. 6.

    Rodrigues JM, Ferreira Leal AP, Buccini DF, Franco OL · Drug discovery today · 2025 · PMID 41241376

    Inflammatory bowel diseases (IBDs) are chronic disorders affecting the gastrointestinal tract, causing severe inflammation and tissue damage. Current treatments often have adverse effects, underscoring the need for alternatives. This article is a short review of host defense peptides (HDPs), which have emerged as promising candidates for IBDs because of their antimicrobial and immunomodulatory properties. The HDPs cited include cathelicidins [e.g. LL-37-Tα1, lipid transfer protein (LTP), C-L, KR…

  7. 7.

    Lipton JM, Catania A, Delgado R · Neuroimmunomodulation · 1998 · PMID 9730684

    It is clear that inflammatory processes contribute to neurodegenerative disease, stroke, closed head injury, encephalitis, and other CNS disorders. These inflammatory processes are marked by local increases in cytokines, in particular tumor necrosis factor-alpha (TNF-alpha). It is important to control such CNS inflammation in order to preserve neural function. The neuroimmunomodulatory peptide alpha-melanocyte-stimulating hormone (alpha-MSH) has been shown to modulate peripheral inflammation by…

  8. 8.

    Gravina AG, Pellegrino R, Durante T, Palladino G, et al. · Cells · 2023 · PMID 37508552

    The melanocortin system is a complex set of molecular mediators and receptors involved in many physiological and homeostatic processes. These include the regulation of melanogenesis, steroidogenesis, neuromodulation and the modulation of inflammatory processes. In the latter context, the system has assumed importance in conditions of chronic digestive inflammation, such as inflammatory bowel diseases (IBD), in which numerous experiences have been accumulated in mouse models of colitis. Indeed, i…

  9. 9.

    Lipton JM, Catania A · Annals of the New York Academy of Sciences · 1998 · PMID 9629264

    The antiinflammatory effects of alpha-melanocyte-stimulating hormone (alpha-MSH) molecules, specifically alpha-MSH(1-13) and its COOH-terminal tripeptide alpha-MSH(11-13), are well established. The peptides have been effective in tests of all major models of inflammation, and more recent tests have been extended to include experimental inflammatory bowel disease, CNS ischemia/reperfusion injury, and bacterial endotoxin-induced inflammation within the brain. The broad effectiveness of alpha-MSH m…

  10. 10.

    Adnan SB, Maarof M, Fauzi MB, Fadilah NIM · International journal of medical sciences · 2025 · PMID 41209547

    Wound healing is a complex and dynamic process that requires the coordination of cellular, molecular, and physiological events to restore tissue integrity. Despite notable advances in treatment strategies, optimizing healing outcomes, particularly in chronic wounds, remains a major challenge. Emerging evidence highlights the therapeutic promise of peptides, especially tripeptides, in accelerating tissue repair through diverse mechanisms. These short peptides regulate key processes such as cell m…

Research Articles

97
  1. 11.

    Elliott RJ, Szabo M, Wagner MJ, Kemp EH, et al. · The Journal of investigative dermatology · 2004 · PMID 15102092

    alpha-MSH signals by binding to the melanocortin-1 receptor (MC-1R) and elevating cyclic AMP in several different cells. The anti-inflammatory properties of this peptide are also believed to be cyclic AMP dependent. The carboxyl terminal tripeptides of alpha-MSH (KPV / KP-D-V) are the smallest minimal sequences reported to prevent inflammation but it is not known if they operate via MC-1R or cyclic AMP. The aim of this study was to examine the intracellular signalling of key MSH and ACTH peptide…

  2. 12.

    Berr AL, Wiese K, Dos Santos G, Koch CM, et al. · Oncogene · 2023 · PMID 37161053

    Vimentin is highly expressed in metastatic cancers, and its expression correlates with poor patient prognoses. However, no causal in vivo studies linking vimentin and non-small cell lung cancer (NSCLC) progression existed until now. We use three complementary in vivo models to show that vimentin is required for the progression of NSCLC. First, we crossed LSL-Kras

  3. 13.

    Sung J, Ju SY, Park S, Jung WK, et al. · Tissue & cell · 2025 · PMID 40073467

    Airborne particulate matter (PM) poses a major environmental risk that impairs skin health by triggering oxidative stress, inflammation, and cell death. In this study, we investigated the protective effects of Lysine-Proline-Valine (KPV)-an endogenous peptide derived from α-melanocyte-stimulating hormone-against oxidative damage and inflammation induced by fine PM (PM

  4. 14.

    Zeng K, Zhu Y, Han Z, Xiong S, et al. · Cell death and differentiation · 2026 · PMID 40935835

    NLRP3 functions as a critical intracellular danger sensor for inflammasome activation, playing a crucial role in autoimmune diseases. Vitiligo progression has been linked to NLRP3, yet its specific involvement in melanocytes of vitiligo remains poorly understood. In this study, we demonstrate that NLRP3 expression is significantly upregulated in the melanocytes of vitiligo patients and melanoma-Treg-induced vitiligo mouse model. Genetic knockout of NLRP3 effectively alleviates vitiligo progressi…

  5. 15.

    Zeng M, Shao A, Li H, Tang Y, et al. · ACS applied materials & interfaces · 2017 · PMID 28349696

    The inflammatory activity of ulcerative colitis plays an important role in the medical treatment. However, accurate and real-time monitoring of the colitis activity with noninvasive bioimaging method is still challenging, especially in distinguishing between chronic and acute colitis. As a good receptor, the oligopeptide transporter (PepT1) is overexpressed in the colonic epithelial cells of chronic ulcerative colitis, which can deliver tripeptide KPV (Lys-Pro-Val, the C-terminal sequence of α-M…

  6. 16.

    Laroui H, Dalmasso G, Nguyen HT, Yan Y, et al. · Gastroenterology · 2010 · PMID 19909746

    One of the challenges to treating inflammatory bowel disease (IBD) is to target the site of inflammation. We engineered nanoparticles (NPs) to deliver an anti-inflammatory tripeptide Lys-Pro-Val (KPV) to the colon and assessed its therapeutic efficacy in a mouse model of colitis. NPs were synthesized by double-emulsion/solvent evaporation. KPV was loaded into the NPs during the first emulsion of the synthesis process. To target KPV to the colon, loaded NPs (NP-KPV) were encapsulated into a polys…

  7. 17.

    Getting SJ, Schiöth HB, Perretti M · The Journal of pharmacology and experimental therapeutics · 2003 · PMID 12750433

    In this study, we analyzed the anti-inflammatory effects of alpha-melanocyte stimulating hormone (MSH)11-13 (KPV) in comparison with other MSH peptides in a model of crystal-induced peritonitis. Systemic treatment of mice with KPV, alpha-MSH, the core melanocortin peptide His-Phe-Arg-Trp, and the melanocontin receptor 3/4 agonist Ac-Nle4-c[Asp5,d-Phe7,Lys10]NH2 ACTH4-10 (MTII) but not the selective MC1-R agonist H-Ser-Ser-Ile-Ile-Ser-His-Phe-Arg-Trp-Gly-Lys-Pro-Val-NH2 (MS05) resulted in a signi…

  8. 18.

    Zhao Y, Xue P, Lin G, Tong M, et al. · Acta biomaterialia · 2022 · PMID 35245681

    Ulcerative colitis (UC) usually occurs in the superficial mucosa of the colorectum. Here, a double-network hydrogel (PMSP) was constructed from maleimided γ-polyglutamic acid and thiolated γ-polyglutamic acid through crosslinking of thiol-maleimide and self-oxidized thiols. PMSP with a negative charge specifically adhered to the inflamed mucosa with positively charged proteins rather than to the healthy mucosa. PMSP exhibited good mechanical strength with storage modulus (G') of 17.6 Pa and a li…

  9. 19.

    Dalmasso G, Charrier-Hisamuddin L, Nguyen HT, Yan Y, et al. · Gastroenterology · 2008 · PMID 18061177

    KPV is a tripeptide (Lys-Pro-Val), which possesses anti-inflammatory properties; however, its mechanisms of action still remain unknown. PepT1 is a di/tripeptide transporter normally expressed in the small intestine and induced in colon during inflammatory bowel disease (IBD). The aim of this study was to 1) investigate whether the KPV anti-inflammatory effect is PepT1-mediated in intestinal epithelian and immune cells, and 2) examine the anti-inflammatory effects in two models of mice colitis.…

  10. 20.

    Bonfiglio V, Camillieri G, Avitabile T, Leggio GM, et al. · Experimental eye research · 2006 · PMID 16965771

    It is known that alpha-melanocyte stimulating hormone (alpha-MSH) may exert anti-inflammatory effects and facilitate reparative processes in different tissues. The effective message sequence of alpha-MSH resides in the COOH-terminal tripeptide alpha-MSH(11-13). This study was undertaken to investigate the effects of topical administration of the COOH-terminal tripeptide sequence of alpha-MSH (alpha-MSH(11-13), KPV) on corneal epithelial wound healing in rabbits and the possible role of nitric ox…

  11. 21.

    Zhang L, Li D, Aierken Y, Zhang J, et al. · Advanced healthcare materials · 2024 · PMID 39252648

    Cardiovascular disease (CVD) is a leading cause of death globally, and vascular calcification (VC) is an important independent risk factor for predicting CVD. Currently, there are no established therapeutic strategies for the treatment of VC. Although recognized combination therapies of nanomedicines can provide effective strategies for disease treatment, the clinical application of nanomedicines is limited because of their complex preparation processes, low drug loading rates, and unpredictable…

  12. 22.

    Kim H, Hong HD, Suh HJ, Shin KS · International journal of biological macromolecules · 2016 · PMID 27131731

    The crude polysaccharide (KPV-0) isolated from Korean persimmon vinegar was fractionated using gel filtration chromatography to enhance the immunostimulatory activity and to identify the structural features of active fraction. Among three fractions, KPV-I obtained in a void volume, demonstrated the potent production of macrophage-stimulating mediators, including tumor necrosis factor-α, interleukin (IL)-6, IL-12, and nitric oxide. KPV-I showed a combined single peak with high molecular weight of…

  13. 23.

    Sun J, Xue P, Liu J, Huang L, et al. · ACS biomaterials science & engineering · 2021 · PMID 34547895

    KPV (Lys-Pro-Val), which is a tripeptide derived from α-MSH (α-melanocyte-stimulating hormone), has an anti-inflammatory effect on colitis. However, KPV solution is very unstable when rectally administered, compromising its therapeutic efficacy. Herein, cysteamine-grafted γ-polyglutamic acid (SH-PGA) was synthesized by conjugating cysteamine with the carboxyl groups of γ-PGA. The synthesized SH-PGA has the thiol grafting amount of 4.5 ± 0.3 mmol/g. Without the use of the cross-linker, the SH-PGA…

  14. 24.

    Pawar K, Kolli CS, Rangari VK, Babu RJ · Journal of pharmaceutical sciences · 2017 · PMID 28343991

    Lysine-proline-valine (KPV) is a C-terminal peptide fragment of α-melanocyte stimulating hormone with potent anti-inflammatory properties. Present study investigates various transdermal enhancement strategies such as iontophoresis (ITP), microneedles (MN), and their combination (ITP + MN) on KPV delivery across dermatomed human skin. KPV attains a positive charge at pH less than 7.0, thus anodal ITP was used. The influence of current strength, KPV concentration, and duration of current applicati…

  15. 25.

    Sun MC, Xu XL, Du Y, Lou XF, et al. · ACS nano · 2021 · PMID 34662120

    Extremely limited drug retention and depigmentation represent the greatest barriers against vitiligo treatment advancement. Here, inspired by biological melanosomes, the primary melanin transporter, we developed biomimetic melanosomes to combat reactive oxygen species (ROS)-mediated melanocyte damage and depigmentation. Briefly, methylprednisolone (MPS) and melanin-mimicking polydopamine (PDA) were encapsulated inside lysine-proline-valine (KPV)-modified deformable liposomes (KPV-Lipos). Owing t…

  16. 26.

    Kannengiesser K, Maaser C, Heidemann J, Luegering A, et al. · Inflammatory bowel diseases · 2008 · PMID 18092346

    Despite some progress in recent years, the options for treating inflammatory bowel disease (IBD) are still dissatisfying, and surgery rates are still high. The anti-inflammatory effects of melanocortin peptides such as alpha-melanocyte-stimulating hormone (alpha-MSH) have been described recently in, for example, dextran sodium sulfate (DSS) colitis in mice. The aim of this study was to investigate the therapeutic potential of the melanocortin-derived tripeptide alpha-MSH(11-13) (KPV) and its mod…

  17. 27.

    Songok AC, Panta P, Doerrler WT, Macnaughtan MA, et al. · PloS one · 2018 · PMID 29953505

    Peptides that exhibit enzymatic or hormonal activities are regulatory factors and desirable therapeutic drugs because of their high target specificity and minimal side effects. Unfortunately, these drugs are susceptible to enzymatic degradation, leading to their rapid elimination and thereby demanding frequent dosage. Structurally modified forms of some peptide drugs have shown enhanced pharmacokinetics, improving their oral bioavailability. Here, we discuss a novel glycomimetic approach to modi…

  18. 28.

    Wu JY, Zuo JL, Liu T, Gao ZL · Zhongguo gu shang = China journal of orthopaedics and traumatology · 2016 · PMID 29282946

    To reveal the characteristics of anatomical and mechanical axes in lower extremities by analyzing full length weight bearing X ray radiographsin patients with knee osteoarthritis(OA). From June 2015 to May 2016, the lower extremity CTA was performed for 20 patients with vascular diseases, and these patients without OA were assigned to the normal group. There were 7 males and 13 females, ranging in age from 24 to 72 years old with an average age of 63.2 years old. The weight bearing full length X…

  19. 29.

    Pawar KR, Mulabagal V, Smith F, Kolli CS, et al. · Biomedical chromatography : BMC · 2015 · PMID 25298219

    A simple, sensitive and stability-indicating high-performance liquid chromatographic (HPLC) assay method was developed and validated for a bioactive peptide, lysine-proline-valine (KPV) in aqueous solutions and skin homogenates. Chromatographic separation was achieved on a reversed phase Phenomenex C18 column (4.6 × 250 mm, packed with 5 µm silica particles) with a gradient mobile phase consisting of 0.1% trifluoroacetic acid (TFA) in water (A) and 0.1% TFA in acetonitrile (B). The proposed HPLC…

  20. 30.

    Xiao B, Xu Z, Viennois E, Zhang Y, et al. · Molecular therapy : the journal of the American Society of Gene Therapy · 2017 · PMID 28143741

    Overcoming adverse effects and selectively delivering drug to target cells are two major challenges in the treatment of ulcerative colitis (UC). Lysine-proline-valine (KPV), a naturally occurring tripeptide, has been shown to attenuate the inflammatory responses of colonic cells. Here, we loaded KPV into hyaluronic acid (HA)-functionalized polymeric nanoparticles (NPs). The resultant HA-KPV-NPs had a desirable particle size (∼272.3 nm) and a slightly negative zeta potential (∼-5.3 mV). These NPs…

  21. 31.

    Richards DB, Lipton JM · Peptides · 1984 · PMID 6333677

    In previous experiments, alpha-MSH (1-13) and ACTH (1-24), which contains the alpha-MSH 1-13 amino acid sequence, were found to reduce fever after central and peripheral administration of low, non-hypothermic doses. Shorter molecules, including alpha-MSH 1-10, had no effect. The idea that the 11-13 amino acid sequence is important to the effect of the parent molecule was tested by giving lysine-proline-valine both centrally and peripherally to rabbits made febrile by IV administration of leukocy…

  22. 32.

    Hiltz ME, Catania A, Lipton JM · Peptides · 1991 · PMID 1788140

    D-Amino acid substitutions in the anti-inflammatory/antipyretic Ac-alpha-MSH(11-13)-NH2 tripeptide of Ac-alpha-MSH(1-13)-NH2 were made and the altered peptides were injected in mice treated with picryl chloride. Ear swelling, measured 3 and 6 h after application of the irritant, was reduced by IP injections of Ac-alpha-MSH(11-13)-NH2, in confirmation of previous observations. Ac-[D-Lys11]alpha-MSH(11-13)-NH2 effected similar anti-inflammatory activity but Ac-[D-Pro12]alpha-MSH(11-13)-NH2 was ina…

  23. 33.

    Barcellini W, Colombo G, La Maestra L, Clerici G, et al. · Journal of leukocyte biology · 2000 · PMID 11073109

    The purpose of the present research was to determine if alpha-melanocyte-stimulating hormone (alpha-MSH) and its C-terminal tripeptide [alpha-MSH (11-13), KPV] alter HIV expression in infected cells. The results indicate that chronically HIV-1-infected promonocytic U1 cells produce alpha-MSH and that immunoneutralization of the endogenous peptide enhances HIV expression. Because U1 cells express the alpha-MSH receptor 1 (MC1R), an autocrine-inhibitory circuit based on the peptide and its recepto…

  24. 34.

    Gatti S, Carlin A, Sordi A, Leonardi P, et al. · The Journal of surgical research · 2006 · PMID 16413580

    alpha-Melanocyte stimulating hormone (alpha-MSH) is an endogenous peptide that has remarkable anti-inflammatory and antimicrobial effects. These activities have been traced to the C-terminal tripeptide Lys-Pro-Val (KPV). A dimer composed of two KPV sequences connected with a Cys-Cys linker, (CKPV)2, is currently under clinical investigation for antimicrobial use. The present research was designed to evaluate effects of (CKPV)(2) on endotoxin-induced host reactions in vitro and in vivo. Effects o…

  25. 35.

    Marotti V, Xu Y, Bohns Michalowski C, Zhang W, et al. · Bioactive materials · 2024 · PMID 37859689

    Current treatments for inflammatory bowel disease (IBD) treatment consist of anti-inflammatory products. In this study, we sought to induce the physiological secretion of glucagon-like peptide 2, a peptide with intestinal growth-promoting activity, via nanoparticles while simultaneously providing with immunomodulation by tailoring the nanoparticle surface. To this end, we developed hybrid lipid hyaluronate-KPV conjugated nanoparticles loaded with teduglutide for combination therapy in IBD. The n…

  26. 36.

    Zhang D, Jiang L, Yu F, Yan P, et al. · Frontiers in pharmacology · 2024 · PMID 39211778

    Inflammatory bowel disease (IBD), as a chronic and recurrent inflammatory bowel diseases with limited therapeutic outcomes, is characterized by immune disorders and intestinal barrier dysfunction. Currently, the most medications used to cure IBD in clinic just temporarily induce and maintain remission with poor response rates and limited outcomes. Therefore, it is urgently necessary to develop an appropriate therapeutic candidate with preferable efficacy and less adverse reaction for curing IBD.…

  27. 37.

    Zhao Y, Huang L, Lin G, Tong M, et al. · International journal of biological macromolecules · 2022 · PMID 36240893

    The general treatment of diabetic wound was use of wound dressings to absorb excess exudate. However, traditional wound dressings neither mimic the skin-like properties nor easily be withdrawn from the wound. Herein, the skin-adaptive three-layered films (AGB) dressing has been designed by alternatively depositing phenylboronic acid-grafted γ-PGA (PBA-PGA) and polyvinyl alcohol (PVA). The thickness of AGB film was only 479 μm and its flexibility was obviously strengthen by the boronic ester cros…

  28. 38.

    Luger TA, Brzoska T · Annals of the rheumatic diseases · 2007 · PMID 17934097

    alpha-Melanocyte-stimulating hormone (alpha-MSH) is a tridecapeptide derived from the proopiomelanocortin by post-translational processing. In addition to its effects on melanocytes, alpha-MSH has potent anti-inflammatory effects when administered systemically or locally. The anti-inflammatory effects of alpha-MSH are mediated by direct effects on cells of the immune system as well as indirectly by affecting the function of resident non-immune cells. alpha-MSH affects several pathways implicated…

  29. 39.

    Shao W, Chen R, Lin G, Ran K, et al. · Biomaterials science · 2021 · PMID 34846053

    The self-healing of chemotherapy-induced oral mucositis is difficult in practice because of both local bacterial infection and severe inflammation. Herein,

  30. 40.

    Carotenuto A, Saviello MR, Auriemma L, Campiglia P, et al. · Chemical biology & drug design · 2007 · PMID 17313459

    Alpha-melanocyte-stimulating hormone (alpha-MSH) is an endogenous linear tridecapeptide with potent anti-inflammatory effects. We firstly demonstrated that alpha-MSH and its C-terminal sequence Lys-Pro-Val [alpha-MSH(11-13)] have antimicrobial effects against two major and representative pathogens: Staphylococcus aureus and Candida albicans. Successively, in an attempt to improve the candidacidal activity of alpha-MSH and to better understand the peptide structure-antifungal activity relations,…

  31. 41.

    Lee JY, Lee J, Jung WK, Je JY, et al. · Cytotechnology · 2026 · PMID 42064835

    Hepatocellular steatosis, an early stage within the non-alcoholic fatty liver disease (NAFLD) spectrum, is characterized by excessive lipid accumulation and oxidative stress in hepatocytes. This study examined the protective role of Lysine-Proline-Valine (KPV), an endogenous tripeptide derived from α-melanocyte-stimulating hormone, against oleic acid (OA)-induced oxidative damage and lipid accumulation in hepatic epithelial HepG2 cells. OA treatment markedly enhanced hepatic lipid deposition by…

  32. 42.

    Hiltz ME, Lipton JM · Peptides · 1990 · PMID 2284205

    Alpha-melanocyte stimulating hormone [alpha-MSH(1-13)] occurs within the CNS, skin, circulation and in other body sites. This tridecapeptide and its COOH-terminal tripeptide, alpha-MSH (11-13), have antipyretic and anti-inflammatory actions. Studies of the anti-inflammatory effects of these molecules have been confined mainly to tests of inhibition of histamine and endogenous pyrogen-induced increases in capillary permeability in rabbits and acute inflammation of ear tissue in mice. The aim in t…

  33. 43.

    Catania A, Grieco P, Randazzo A, Novellino E, et al. · The journal of peptide research : official journal of the American Peptide Society · 2005 · PMID 15946192

    Previous research has shown that the immunomodulatory peptide alpha-melanocyte-stimulating hormone (alpha-MSH) and its carboxy-terminal tripeptide KPV (Lys-Pro-Val alpha-MSH11-13) have antimicrobial influences. By inserting a Cys-Cys linker between two units of KPV, we designed the dimer [Ac-CKPV]2 that showed excellent candidacidal effects in pilot tests and was the subject of further investigations. [Ac-CKPV]2 was active against azole-resistant Candida spp. Therefore, the molecule appeared a p…

  34. 44.

    Poole S, Bristow AF, Lorenzetti BB, Das RE, et al. · British journal of pharmacology · 1992 · PMID 1327383

    1. The hyperalgesic effects of interleukin-1 beta (IL-1 beta) and prostaglandin E2 (PGE2) were measured in rats. 2. Hyperalgesic responses to IL-1 beta were inhibited in a dose-dependent manner by alpha-melanocyte stimulating hormone (alpha-MSH)-related peptides with the following order of potency: [N1(4),D-Phe7]alpha-MSH greater than alpha-MSH greater than Lys-D-Pro-Val greater than Lys-Pro-Val greater than Lys-D-Pro-Thr greater than D-Lys-Pro-Thr. 3. Hyperalgesic responses to PGE2 were not inh…

  35. 45.

    Liu DH, Su YP, Zhang W, Lou SF, et al. · Sheng li xue bao : [Acta physiologica Sinica] · 2001 · PMID 11833422

    To observe the changes in aldosterone binding activity of kidney cytosols after pathological stress in rats and the regulation, binding capacity (Rt) and apparent dissociation constant (Kd) of aldosterone binding activity of kidney cytosols in normal, low-degree or heavy-degree scalded rats were measured by radioligand binding assay using [3H]aldosterone as the ligand. Changes in Rt and Kd of aldosterone binding activity were observed after injection of anti-rat TNF alpha and IL-1 beta antibodie…

  36. 46.

    Piazza A, Comandatore F, Romeri F, Brilli M, et al. · Microbial drug resistance (Larchmont, N.Y.) · 2019 · PMID 30589602

    In the past years, the

  37. 47.

    Schaible EV, Steinsträßer A, Jahn-Eimermacher A, Luh C, et al. · PloS one · 2013 · PMID 23940690

    Following traumatic brain injury (TBI) neuroinflammatory processes promote neuronal cell loss. Alpha-melanocyte-stimulating hormone (α-MSH) is a neuropeptide with immunomodulatory properties, which may offer neuroprotection. Due to short half-life and pigmentary side-effects of α-MSH, the C-terminal tripeptide α-MSH(11-13) may be an anti-inflammatory alternative. The present study investigated the mRNA concentrations of the precursor hormone proopiomelanocortin (POMC) and of melanocortin recepto…

  38. 48.

    Land SC · International journal of physiology, pathophysiology and pharmacology · 2012 · PMID 22837805

    Chemokine signaling from airway epithelium regulates macrophage recruitment to the lung in inflammatory diseases such as asthma. This study investigates the mechanism by which the α-melanocyte stimulating hormone-derived tripeptide, KPV, and the agonist of the dominant melanocortin receptor in airway epithelium (MC3R), γ-melanocyte stimulating hormone (γ-MSH), suppress inflammation in immortalised human bronchial airway epithelium. TNFα and rhino syncitial virus (RSV)-evoked nuclear factor-κB (N…

  39. 49.

    Liu DH, Su YP, Zhang W, Lou SF, et al. · Burns : journal of the International Society for Burn Injuries · 2002 · PMID 12052369

    Preliminary experiments indicated that target cells were resistant to glucocorticoid (GC) after pathological stress. This study was designed to investigate the alterations in plasma corticosterone level and GC receptor (GR) of liver cytosols, to assess the relative inflammatory cytokines contribution to GC resistant, and to observe the action of alpha-melanocyte-stimulating hormone (alpha-MSH) on the potential implications of glucocorticord regulatory effects in burned rats. Male Wistar rats (we…

  40. 50.

    Chavatte P, Yous S, Lesieur D, Hénichart JP · The Journal of pharmacy and pharmacology · 2001 · PMID 11480545

    Alpha-melanocyte stimulating hormone (alpha-MSH) is an endogenous linear tridecapeptide which interacts with the melanocortin receptors (MC1-R to MC5-R) to mediate its biological effects. Antipyretic and anti-inflammatory activities of alpha-MSH are due to the COOH-terminal peptide sequence, Lys-Pro-Val (alpha-MSH[11-13]). This tripeptide might be useful as a therapeutic agent in the control of fever and inflammatory reactions. With this aim, a theoretical conformational study of the tripeptide…

  41. 51.

    Singh M, Mukhopadhyay K · Antimicrobial agents and chemotherapy · 2011 · PMID 21282427

    Alpha-melanocyte-stimulating hormone (α-MSH) is an endogenous neuropeptide that is known for its anti-inflammatory and antipyretic activities. We recently demonstrated that α-MSH possesses staphylocidal activity and causes bacterial membrane damage. To understand the role of its amino acid sequences in the staphylocidal mechanism, in the present study we investigated the antimicrobial activities of different fragments of α-MSH, i.e., α-MSH(6-13), α-MSH(11-13), and α-MSH(1-5), and compared them w…

  42. 52.

    Cutuli M, Cristiani S, Lipton JM, Catania A · Journal of leukocyte biology · 2000 · PMID 10670585

    The presence of the ancient anti-inflammatory peptide alpha-melanocyte-stimulating hormone [alpha-MSH (1-13), SYSMEHFRWGKPV] in barrier organs such as gut and skin suggests a role in the nonspecific (innate) host defense. alpha-MSH and and its carboxy-terminal tripeptide (11-13, KPV) were determined to have antimicrobial influences against two major and representative pathogens: Staphylococcus aureus and Candida albicans. alpha-MSH peptides significantly inhibited S. aureus colony formation and…

  43. 53.

    Böhm M, Luger T · Experimental dermatology · 2019 · PMID 30661264

    Cutaneous wound healing is a complex process divided into different phases, that is an inflammatory, proliferative and remodelling phase. During these phases, a variety of resident skin cell types but also cells of the immune system orchestrate the healing process. In the last year, it has been shown that the majority of cutaneous cell types express the melanocortin 1 receptor (MC1R) that binds α-melanocyte-stimulating hormone (α-MSH) with high affinity and elicits pleiotropic biological effects…

  44. 54.

    Wu Y, Sun M, Wang D, Li G, et al. · Biomaterials science · 2019 · PMID 31408067

    To effectively alleviate acute severe ulcerative colitis (ASUC), we developed a colon-specific delivery system-PLGA-KPV/MMT/CS multifunctional medicinal nanoparticles loaded with cyclosporine A (CyA). The lysine-proline-valine (KPV) tripeptide, which possesses anti-inflammatory properties and high affinity to peptide transporter 1 (PepT1), can target therapy-related cells (colonic epithelial cells and macrophages) via overexpression of PepT1. Montmorillonite (MMT)/chitosan (CS) coating can reduc…

  45. 55.

    Cheng J, Wu P, Li C, Han Y, et al. · Science advances · 2026 · PMID 41533788

    Oral delivery of peptide therapeutics remains challenging due to gastrointestinal (GI) degradation and poor intestinal absorption. Here, we propose a self-immolative peptide prodrug conjugate (SIPPC) platform for inflammation-targeted oral delivery, integrating a hydrophilic polyethylene glycol segment, a reactive oxygen species (ROS)-responsive hydrophobic self-immolative module, and a hydrolyzable scaffold, which collectively enable spontaneous assembly into micelle-like nanoparticles. Using t…

  46. 56.

    Grieco P, Rossi C, Colombo G, Gatti S, et al. · Journal of medicinal chemistry · 2003 · PMID 12593664

    alpha-Melanocyte stimulating hormone (alpha-MSH) is an endogenous linear tridecapeptide with potent antiinflammatory effects. We recently demonstrated that alpha-MSH and its C-terminal sequence Lys-Pro-Val (alpha-MSH (11-13)) have antimicrobial effects against two major and representative pathogens: Staphylococcus aureus and Candida albicans. In an attempt to improve the candidacidal activity of alpha-MSH and to better understand the peptide structure-antifungal activity relations, we designed a…

  47. 57.

    Macaluso A, McCoy D, Ceriani G, Watanabe T, et al. · The Journal of neuroscience : the official journal of the Society for Neuroscience · 1994 · PMID 8158274

    alpha-Melanocyte-stimulating hormone (alpha-MSH1-13) and its COOH-terminal tripeptide alpha-MSH11-13 (Lys Pro Val) inhibit inflammation when administered systemically. Recent evidence indicates that alpha-MSH1-13 can likewise inhibit inflammation in the skin solely via an action within the brain. Because of the potential importance of this discovery to understanding the control of inflammation and because alpha-MSH molecules might be useful for treatment of inflammation, experiments were perform…

  48. 58.

    Galimberti D, Baron P, Meda L, Prat E, et al. · Biochemical and biophysical research communications · 1999 · PMID 10486285

    Alpha-melanocyte stimulating hormone (alpha-MSH) is an ancient tridecapeptide with potent inhibitory activity in all major forms of inflammation. The anti-inflammatory message sequence of alpha-MSH resides in the COOH-terminal tripeptide alpha-MSH[11-13]. We tested the influence of alpha-MSH[1-13] and of alpha-MSH[11-13] in a cultured murine microglia cell line known to produce nitric oxide (NO(-)(2)) and tumor necrosis factor (TNFalpha) when stimulated with beta-amyloid protein (Abeta). Melanoc…

  49. 59.

    Watanabe T, Hiltz ME, Catania A, Lipton JM · Brain research bulletin · 1993 · PMID 8397057

    Interleukin-1 (IL-1) is a proinflammatory cytokine, alpha-MSH(1-13) molecules inhibit inflammation induced by cytokines, other mediators of inflammation, and by peripheral irritants. D-valine substitution in the antiinflammatory/antipyretic message sequence [alpha-MSH(11-13), Lys-Pro-Val] of alpha-MSH(1-13) increases the activity of the tripeptide. Our aim was to learn if D-valine substitution also enhances the antiinflammatory activity of the entire alpha-MSH(1-13) molecule and to determine if…

  50. 60.

    Salk J, van Wezel AL, Stoeckel P, van Steenis G, et al. · Developments in biological standardization · 1981 · PMID 7194827

    This paper contains a summary of the principles upon which the preparation and use of killed poliovirus vaccine (KPV) are based, as well as a summary of earlier and more recent work suggesting the feasibility of formulating a KPV preparation that would be fully and durably effective in a one- or two-dose regimen. The essential factor in the preparation of such a vaccine is the inclusion of a sufficient mass of the immunizing antigen, for each of the three antigenic types of poliovirus, to induce…

  51. 61.

    Mumtaz S, Behera S, Mukhopadhyay K · ACS omega · 2020 · PMID 33195893

    Stationary phase

  52. 62.

    Viennois E, Ingersoll SA, Ayyadurai S, Zhao Y, et al. · Cellular and molecular gastroenterology and hepatology · 2016 · PMID 27458604

    The human intestinal peptide transporter 1, hPepT1, is expressed in the small intestine at low levels in the healthy colon and upregulated during inflammatory bowel disease. hPepT1 plays a role in mouse colitis and human studies have demonstrated that chronic intestinal inflammation leads to colorectal cancer (colitis-associated cancer; CAC). Hence, we assessed here the role of PepT1 in CAC. Mice with hPepT1 overexpression in intestinal epithelial cells (TG) or PepT1 (PepT1-KO) deletion were use…

  53. 63.

    Uehara Y, Shimizu H, Sato N, Mura YS, et al. · Peptides · 1993 · PMID 8387184

    The carboxyl-terminal tripeptide of alpha-MSH(1-13), Lys-Pro-Val, antagonizes anorexia induced by interleukin-1 beta (IL-1). The present studies were undertaken to determine if the Lys-Pro dipeptide portion of this tripeptide likewise antagonizes anorexia induced by ICV administration of 0.5 pmol IL-1 in rats previously deprived of food. This dose of Lys-Pro did significantly attenuate the IL-1-induced anorexia, but only for 1 h after infusion. Simultaneous administration of a larger dose (5.0 p…

  54. 64.

    He K, Wan D, Li S, Yuan G, et al. · Pediatric nephrology (Berlin, Germany) · 2024 · PMID 38041747

    Split kidney function (SKF) is critical for treatment decision in pediatric patients with hydronephrosis and is commonly measured using renal scintigraphy (RS). Non-contrast-enhanced magnetic resonance urography (NCE-MRU) is increasingly used in clinical practice. This study aimed to investigate the feasibility of using NCE-MRU as an alternative to estimate SKF in pediatric patients with hydronephrosis, compared to RS. Seventy-five pediatric patients with hydronephrosis were included in this ret…

  55. 65.

    Słoń JI, Siemion IZ, Zimecki M, Wieczorek Z · Archivum immunologiae et therapiae experimentalis · 1995 · PMID 8744698

    The effects of Lys residue deletion from peptides, related to immunosuppressive regions of lactoferrin (LF), were studied in the humoral and cellular immune responses to sheep erythrocytes (SRBC) in mice. We found that the deletion of Lys residue, vicinal to Pro, influences mostly the immunomodulatory activity of short fragments (tetra-, and pentapeptides) of immunosuppressive 231-245 mini-domain of LF. The activity of longer peptides, related to this mini-domain, is influenced to much lower ext…

  56. 66.

    Deeter LB, Martin LW, Lipton JM · Peptides · 1988 · PMID 2854626

    alpha-Melanocyte stimulating hormone (alpha-MSH 1-13) has marked antipyretic effects when administered centrally or peripherally in small doses. A C-terminal fragment, alpha-MSH (11-13), contains an antipyretic message sequence of alpha-MSH; however, the lesser potency of this fragment relative to that of the entire molecule suggests that other amino acids of the alpha-MSH sequence are essential for the full antipyretic effect. Graded doses of alpha-MSH (11-13) (Ac LysProVal NH2), alpha-MSH (10-…

  57. 67.

    Uehara Y, Shimizu H, Sato N, Tanaka Y, et al. · European journal of pharmacology · 1992 · PMID 1330615

    Interleukin-1 beta (IL-1), a cytokine released from inflammatory cells, is thought to be involved in the anorexia associated with severe infection. To assess a possible role of the amino acid sequence found in the supposed IL-1 receptor binding sites, we determined the antagonistic effects of alpha-melanocyte-stimulating hormone (MSH) and the carboxyl-terminal tripeptide of alpha-MSH-(11-13) (alpha-MSH-(11-13)) on the anorexia induced by intracerebroventricular (i.c.v.) administration of 0.5 pmo…

  58. 68.

    Shimizu H, Tanaka Y, Sato N, Mori M · Peptides · 1995 · PMID 7479291

    alpha-Melanocyte-stimulating hormone (MSH) antagonizes the binding of interleukin-1 beta (IL-1) to its type I receptors on T cells. IL-1 modulates insulin secretion in the insulin-secreting tumor cell line, HIT-T 15 cells. In the present studies, we examined a hypothesis that alpha-MSH may modulate insulin secretion in HIT-T 15 cells. The addition of alpha-MSH over the concentrations of 10(-10) M inhibited insulin secretion for 4 h. In addition, the carboxyl-terminal tripeptide of alpha-MSH [alp…

  59. 69.

    Lyson K, Ceriani G, Takashima A, Catania A, et al. · Neuroimmunomodulation · 1994 · PMID 7489322

    alpha-Melanocyte-stimulating hormone (alpha-MSH1-13), a peptide derived from proopiomelanocortin, has remarkable anti-inflammatory and antipyretic activities. This peptide and a tripeptide that forms the COOH-terminal portion of the molecule (alpha-MSH11-13; Lys Pro Val) inhibit inflammation when given centrally or peripherally. Because of the similarity in their actions, the tripeptide has been presumed to be the amino acid message sequence underlying the effects of alpha-MSH1-13. To test the p…

  60. 70.

    Hiltz ME, Catania A, Lipton JM · Cytokine · 1992 · PMID 1325196

    The neuropeptide alpha-melanocyte stimulating hormone [alpha-MSH(1-13)] occurs in the pituitary, brain, skin and other tissues and receptors for this molecule are likewise widespread. In previous research, this tridecapeptide, which shares its amino acid sequence with ACTH(1-13), was shown to have both potent antipyretic activity and a role in the endogenous control of the febrile response. alpha-MSH(1-13) and its COOH-terminal tripeptide were subsequently found to inhibit inflammation induced b…

  61. 71.

    Liu DH, Su YP, Zhang W, Lu SF, et al. · Critical care medicine · 2002 · PMID 11990926

    As effectors, glucocorticoid and mineralocorticoid receptors play an important role in pathologic stress. This study was designed to observe the changes in glucocorticoid receptor of liver cytosols and mineralocorticoid receptor of kidney cytosols after pathologic stress in rats. Controlled laboratory study. Medical university. Male Wistar rats (weight range, 180-200 g). Rats received a low-degree or heavy-degree immersion scald that covered 10% or 35% total body surface area and were randomly d…

  62. 72.

    Masman MF, Somlai C, Garibotto FM, Rodríguez AM, et al. · Bioorganic & medicinal chemistry · 2008 · PMID 18346897

    The synthesis, in vitro evaluation and conformational study of His-Phe-Arg-Trp-Gly-Lys-Pro-Val-NH(2) and analogues acting as antifungal agents are reported. Among them, His-Phe-Lys-Trp-Gly-Arg-Phe-Val-NH(2) exhibited a moderate but significant antifungal activity against Cryptococcus neoformans, Candida albicans and Candida tropicalis. A theoretical study allows us to propose a biologically relevant conformation for these octapeptides acting as antifungal agents. In addition, these theoretical c…

  63. 73.

    Mitra S, Mondal AH, Mukhopadhyay K · World journal of microbiology & biotechnology · 2022 · PMID 35972627

    In an attempt to develop potent and non-toxic antimicrobial agent, the palmitoylated analogue of α-melanocyte stimulating hormone(11-13), Pal-α-MSH(11-13) was conjugated with gold nanoparticles (GNPs) for the first time and the efficacy of derived complex was investigated against two strains of Staphylococccus aureus. The GNPs were synthesized using tri-sodium citrate as reductant and Pal-α-MSH(11-13) was conjugated thereafter. The particles were characterised by UV-vis spectroscopy, transmissio…

  64. 74.

    Böhm M, Apel M, Sugawara K, Brehler R, et al. · The Journal of allergy and clinical immunology · 2012 · PMID 22178636

    Little is known about the effect of neuropeptides on basophils, which are important effector cells in immune and allergic responses. This study aimed at revealing the role of α-melanocyte-stimulating hormone (α-MSH) on basophil function. Expression of melanocortin receptors and proopiomelanocortin (POMC) was analyzed by means of RT-PCR, Western immunoblotting, fluorescence-activated cell sorting, and double-immunofluorescence analysis. Signal transduction studies included cyclic AMP and Ca(2+) m…

  65. 75.

    Kelly JM, Moir AJ, Carlson K, Yang Y, et al. · Peptides · 2006 · PMID 16274845

    alpha-MSH is an anti-inflammatory peptide which signals by binding to the melanocortin-1 receptor (MC1R) and elevating cyclic AMP in several different cells and tissues. The carboxyl terminal peptides of alpha-MSH (KPV/GKPV) are the smallest minimal sequences that prevent inflammation, but it is not known if they operate via MC1R or cyclic AMP. The aim of this study was to examine the intracellular signaling potential of the GKPV peptide sequence when immobilized to polystyrene beads via a polye…

  66. 76.

    Cody WL, Wilkes BC, Muska BJ, Hruby VJ, et al. · Journal of medicinal chemistry · 1984 · PMID 6332195

    In previous work we reported that [Cys4,Cys10]-alpha-MSH (II) and Ac-[Cys4,Cys10]-alpha-MSH4-13-NH2 (III) were superpotent melanotropins. Ac-[Cys4,Cys10]-alpha-MSH4-10-NH2 (VI), which constitutes the cyclic analogue of the putative active site sequence -Met4-Glu5-His6-Phe7-Arg8-Trp9-Gly10- of alpha-MSH, was much less active. In the present investigation the contribution of the Lys11 and Pro12 residues of the C-terminal carboxamide tripeptide -Lys11-Pro12-Val13-NH2 to the potency of Cys4,Cys10 co…

  67. 77.

    Eberle A, Schwyzer R · Clinical endocrinology · 1976 · PMID 212233

    The purpose of this investigation was to elucidate the biological significance of lysine11 and of the tripeptide sequence =Lys-Pro-Val-NH2 for the biological activity of alpha-melanocyte-stimulating hormone. To this end the in vitro melanotropic activities of twenty-four synthetic peptides related to the hormone were determined. Extension or reduction of the length of the lysine11 side chain results in a marked decrease of the melanotropic potency of the respective analogue. The C-terminal tripe…

  68. 78.

    Muceniece R, Krigere L, Süli-Vargha H, Wikberg JE · Peptides · 2003 · PMID 12895656

    The C-terminal tripeptide of melanocyte-stimulating hormone, MSH (11-13) (Lys-Pro-Val), possesses strong anti-inflammatory actions, which are mediated via mechanisms that are not fully understood. To shed more light into these mechanisms we have here synthesised and evaluated the activities of L- and D-Val substituted cyclic modifications of MSH (11-13) on nitric oxide (NO) in macrophage RAW 264.7 cells, as well as on binding to melanocortin receptors (MCRs) in B16-F1 and MCR expressing insect c…

  69. 79.

    Mandrika I, Muceniece R, Wikberg JE · Biochemical pharmacology · 2001 · PMID 11239505

    The pro-opiomelanocortin-derived peptide alpha-melanocyte-stimulating hormone (alpha-MSH) mediates broad anti-inflammatory and immunomodulatory effects, which include inhibition of the production and release of proinflammatory cytokines and nitric oxide (NO) from macrophages. We investigated the effects of alpha-MSH, alpha-MSH(1-10), and alpha-MSH(11-13) on NO production and nuclear factor-kappaB (NF-kappaB) translocation in RAW 264.7 macrophages. After stimulation of the cells with bacterial li…

  70. 80.

    Sakurai N, Ara T, Ogata Y, Sano R, et al. · Nucleic acids research · 2011 · PMID 21097783

    Correlations of gene-to-gene co-expression and metabolite-to-metabolite co-accumulation calculated from large amounts of transcriptome and metabolome data are useful for uncovering unknown functions of genes, functional diversities of gene family members and regulatory mechanisms of metabolic pathway flows. Many databases and tools are available to interpret quantitative transcriptome and metabolome data, but there are only limited ones that connect correlation data to biological knowledge and c…

  71. 81.

    Catania A, Garofalo L, Cutuli M, Gringeri A, et al. · Peptides · 1998 · PMID 9700761

    Melanocortins are proopiomelanocortin-derived peptides that include adrenocorticotropic hormone [ACTH (1-39)], alpha-melanocyte-stimulating hormone [alpha-MSH (1-13)], and related amino acid sequences. Melanocortin peptides have potent antiinflammatory/anticytokine activity. Because cytokines such as interleukin 1 (IL-1) and tumor necrosis factor (TNF) can be detrimental in HIV-infected patients, we investigated the effects of melanocortins on production of IL-1 and TNF alpha in the blood of HIV…

  72. 82.

    Haskell-Luevano C, Holder JR, Monck EK, Bauzo RM · Journal of medicinal chemistry · 2001 · PMID 11405661

    The central melanocortin receptors, melanocortin-4 (MC4R) and melanocortin-3 (MC3R), are involved in the regulation of satiety and energy homeostasis. The MC4R in particular has become a pharmaceutical industry drug target due to its direct involvement in the regulation of food intake and its potential therapeutic application for the treatment of obesity-related diseases. The melanocortin receptors are stimulated by the native ligand, alpha-melanocyte stimulating hormone (alpha-MSH). The potent…

  73. 83.

    Charnley M, Moir AJ, Douglas CW, Haycock JW · Peptides · 2008 · PMID 18355945

    The melanocortin peptides alpha-MSH, Lys-Pro-Val and Lys-Pro-D-Val are known to be potent anti-inflammatory agents; however their role as antibacterial peptides is less clear. The aim of this study was to determine whether these peptides displayed antibacterial properties, and specifically whether the Lys-Pro-D-Val tripeptide was more potent than Lys-Pro-Val, consistent with their anti-inflammatory actions. alpha-MSH, Ac-Lys-Pro-D-Val-NH2 and Ac-Lys-Pro-Val-NH2 were found to be antibacterial aga…

  74. 84.

    Delgado R, Carlin A, Airaghi L, Demitri MT, et al. · Journal of leukocyte biology · 1998 · PMID 9620667

    Inflammatory processes contribute to neurodegenerative disease, stroke, encephalitis, and other central nervous system (CNS) disorders. Activated microglia are a source of cytokines and other inflammatory agents within the CNS and it is therefore important to control glial function in order to preserve neural cells. Melanocortin peptides are pro-opiomelanocortin-derived amino acid sequences that include alpha-melanocyte-stimulating hormone (alpha-MSH) and adrenocorticotropic hormone (ACTH). Thes…

  75. 85.

    Hiltz ME, Lipton JM · FASEB journal : official publication of the Federation of American Societies for Experimental Biology · 1989 · PMID 2550304

    The endogenous neuropeptide alpha-melanocyte stimulating hormone (alpha-MSH 1-13), previously found to have marked antipyretic activity, inhibits histamine-induced increases in vasopermeability. The primary antipyretic amino acid message sequence is believed to be the COOH-terminal trieptide, lysine-proline-valine. In recent preliminary research this tripeptide inhibited increases in vasopermeability, raising the possibility that this portion of the alpha-MSH molecule has general antiinflammator…

  76. 86.

    Li D, Shangguan J, Yu F, Lin G, et al. · ACS applied materials & interfaces · 2024 · PMID 38289234

    The pathogenesis of ulcerative colitis (UC) is associated with the shedding of the gut mucus. Herein, inspired by the biological functions of mucus, growth factors-loaded in situ hydrogel (PHE-EK) was designed for UC treatment by integrating dihydrocaffeic acid-modified poloxamer as a thermosensitive material with hyaluronic acid (colitis-specific adhesive), epigallocatechin-3-gallate (antibacterial agent), and bioactive factors (KPV tripeptide and epidermal growth factor). PHE-EK presented good…

  77. 87.

    Can VC, Locke IC, Kaneva MK, Kerrigan MJP, et al. · European journal of pharmacology · 2020 · PMID 32004526

    Human melanocortin MC1 and MC3 receptors expressed on C-20/A4 chondrocytes exhibit chondroprotective and anti-inflammatory effects when activated by melanocortin peptides. Nearly 9 million people in the UK suffer from osteoarthritis, and bacterial infections play a role in its development. Here, we evaluate the effect of a panel of melanocortin peptides with different selectivity for human melanocortin MC1 (α-MSH, BMS-470539 dihydrochloride) and MC3 ([DTrp

  78. 88.

    Haskell-Luevano C, Nikiforovich G, Sharma SD, Yang YK, et al. · Journal of medicinal chemistry · 1997 · PMID 9171884

    Examination of conformationally constrained melanotropin peptide (Ac-Nle4-c[Asp5-His-Phe7-Arg-Trp9-Ala-Lys]-NH2) on four human melanotropin receptors (hMC1R, hMC3R, hMC4R, and hMC5R) resulted in identifying the importance of ligand stereochemistry at positions 5, 7, and 9 for agonist binding affinity and receptor selectivity. A trend in ligand structure-activity relationships emerged for these peptides, with the hMC1R and hMC4R possessing similar tendencies, as did the hMC3R and hMC5R. alpha-MSH…

  79. 89.

    Ceriani G, Macaluso A, Catania A, Lipton JM · Neuroendocrinology · 1994 · PMID 8127402

    The neuropeptide alpha-melanocyte-stimulating hormone (alpha-MSH) has potent antipyretic and antiinflammatory properties. When administered systemically, the naturally occurring molecule and its COOH-terminal tripeptide sequence inhibit inflammation induced by peripherally applied irritants and intradermal injections of mediators of inflammation such as interleukin-1 (IL-1), interleukin-6 (IL-6), and tumor necrosis factor-alpha (TNF alpha). We recently found that alpha-MSH can act solely within…

  80. 90.

    Haskell-Luevano C, Sawyer TK, Trumpp-Kallmeyer S, Bikker JA, et al. · Drug design and discovery · 1996 · PMID 9017363

    Three-dimensional molecular models of the human melanocortin receptor (hMC1R) have been developed based upon the electron cryo-microscopic structure of bacteriorhodopsin and the electron density footprint of bovine rhodopsin. alpha-Melanocyte-stimulating hormone, Ac-Ser-Tyr-Ser-Met4-Glu-His-Phe7-Arg-Trp-Gly-Lys-Pro-Val-NH2 (alpha-MSH, alpha-melanotropin), and the superpotent, prolonged acting agonists, Ac-Ser-Tyr-Ser-Nle4-Glu-His-DPhe7-Arg-Trp-Gly-Lys-Pro-Val-NH2 (NDP-MSH) and Ac-Nle4-c[Asp5-His…

  81. 91.

    Kisary J, Zsak L · Avian pathology : journal of the W.V.P.A · 1983 · PMID 18766799

    DVE virus strains isolated from ducks (KPV strain), geese (KLM strain) and an attenuated strain designated DP were compared. Geese vaccinated with the avirulent strain showed 100% protection against the KPV strain, but no or only partial protection against strain KLM, depending on age and sex. Protection against the KLM strain was achieved by using a vaccine containing an avirulent strain and a strain of medium virulence. In goose embryo fibroblast (GEF) cell cultures the virulent strains caused…

  82. 92.

    Schiöth HB, Muceniece R, Mutule I, Wikberg JE · Basic & clinical pharmacology & toxicology · 2006 · PMID 17040213

    The C-terminal tripeptide of the alpha-melanocyte stimulating hormone (alpha-MSH11-13) possesses strong antiinflammatory activity without known cellular target. In order to better understand the structural requirements for function of such motif, we designed, synthesized and tested out Trp- and Tyr-containing analogues of the alpha-MSH11-13. Seven alpha-MSH11-13 analogues were synthesized and characterized for their binding to the melanocortin receptors recombinantly expressed in insect (Sf9) ce…

  83. 93.

    Bednarek MA, MacNeil T, Tang R, Fong TM, et al. · Peptides · 2007 · PMID 17376561

    Alpha-melanotropin, Ac-Ser(1)-Tyr-Ser-Met-Glu-His(6)-Phe(7)-Arg(8)-Trp(9)-Gly-Lys-Pro-Val(13)-NH(2)(1), is a non-selective endogenous agonist for the melanocortin receptor 5; the receptor present in various peripheral tissues and in the brain, cortex and cerebellum. Most of the synthetic analogs of alphaMSH, including a broadly used and more potent the NDP-alphaMSH peptide, Ac-Ser(1)-Tyr-Ser-Nle(4)-Glu-His(6)-D-Phe(7)-Arg(8)-Trp(9)-Gly-Lys-Pro-Val(13)-NH(2), are also not particularly selective f…

  84. 94.

    Wang W, Wang Z, Lin X, Wang Z, et al. · Talanta · 2012 · PMID 23141346

    In this work, a reflux injection mode for the cross form micro-fluidic chip was studied. This injection mode could flexibly control the length of sample plug from less than one channel width (<83 μm) to tens of channel widths (millimeter-sized) by adjusting the injection time. Namely, the separation resolution or sample detection sensitivity could be selectively improved by changing injection time. Composed of four steps, the reflux injection mode alleviated the electrophoretic sampling bias and…

  85. 95.

    Ji HX, Zou YL, Duan JJ, Jia ZR, et al. · PloS one · 2013 · PMID 23457491

    In this study, we examined anti-fungal and anti-inflammatory effects of the synthetic melanocortin peptide (Ac-Cys-Lys-Pro-Val-NH2)2 or (CKPV)2 against Candida albicans vaginitis. Our in vitro results showed that (CKPV)2 dose-dependently inhibited Candida albicans colonies formation. In a rat Candida albicans vaginitis model, (CKPV)2 significantly inhibited vaginal Candida albicans survival and macrophages sub-epithelial mucosa infiltration. For mechanisms study, we observed that (CKPV)2 inhibit…

  86. 96.

    Jeney A, Kopper L, Nagy P, Lapis K, et al. · Cancer chemotherapy and pharmacology · 1986 · PMID 3948298

    The antitumor action of the 2-chloroethylnitrosocarbamoyl derivatives of peptides related to the 9-13 amino acid residues of alpha-MSH/ACTH and of the C-terminal tetrapeptide analogue of gastrin have been investigated. Series of 2-chloroethylnitrosoureas attached to amino acids, di-, tri-, tetra-, or pentapeptides were examined in a primary screening system. Among these compounds the Pro-Val-, Lys-Pro-Val-, and Trp-Gly-Lys-Pro-Val-containing 2-chloroethylnitrosocarbamoyl groups were the most eff…

  87. 97.

    Joseph CG, Wilczynski A, Holder JR, Xiang Z, et al. · Peptides · 2003 · PMID 15127941

    Agouti-related protein (AGRP) is one of only two known endogenous antagonists of G-protein coupled receptors (GPCRs). Specifically, AGRP antagonizes the brain melanocortin-3 and -4 receptors involved in energy homeostasis, regulation of feeding behavior, and obesity. Alpha-melanocyte stimulating hormone (alpha-MSH) is one of the known endogenous agonists for these receptors. It has been hypothesized that the Arg-Phe-Phe (111-113) human AGRP amino acids may be mimicking the melanocortin agonist P…

  88. 98.

    Cody WL, Wilkes BC, Hruby VJ · Journal of chromatography · 1984 · PMID 6526885

    alpha-Melanotropin (alpha-MSH) is a linear tridecapeptide (Ac-Ser-Tyr-Ser-Met-Glu-His-Phe-Arg-Trp-Gly-Lys-Pro-Val-NH2), that is primarily known for its ability to stimulate melanosome dispersion within integumental melanocytes (F. J. H. Tilders, D. F. Swaab and T. B. van Wimersma Greidanus (Editors), Frontiers of Hormone Research, Vol. 4, Karger, Basel, 1977; J. Ramachandran, S. W. Farmer, S. Liles and C. H. Li, Biochim. Biophys. Acta, 428 (1976) 347). In our efforts to understand the relationsh…

  89. 99.

    Simeth J, Aryal M, Owen D, Cuneo K, et al. · Advances in radiation oncology · 2022 · PMID 35496263

    Global and regional liver function assessments are important for defining the magnitude and spatial distribution of dose to preserve functional liver parenchyma and reduce incidence of hepatotoxicity from radiation therapy for intrahepatic cancer treatment. This individualized liver function-guided radiation therapy strategy is critical for patients with heterogeneous and poor liver function, often observed in cirrhotic patients treated for hepatocellular carcinoma. This study aimed to validate…

  90. 100.

    Porunkevich EA, Skuinbsh AA, Chipens GI · Biokhimiia (Moscow, Russia) · 1976 · PMID 192338

    The influence of fragment ACTH 11-14 analogues with amino acid sequences H-Lys-Pro-Val-Gly-OH (fragment I) and H-Lys-Pro-Val-Gly-NH2 (fragment II), possessing structural elements, similar for certain groups of peptide hormones and kinins, on lipolytic effect of ACTH in adipose tissue and isolated epydidymal fat cells of rat, was studied. Both fragments have no effect on the lipolysis; they potentiate the ACTH-induced lipolysis 1,5--2,0 fold, but do not alter the maximal effect at concentrations…

  91. 101.

    Montagnon BJ, Fanget B, Nicolas AJ · Developments in biological standardization · 1981 · PMID 6785126

    As the increasing shortage of monkeys is a reality, the application of an alternative cell substrate for large-scale production of Killed Poliomyelitis Vaccine (KPV) was studied. Through progress of scientific knowledge the non-tumorigenic VERO cell line was considered to be a suitable alternative cell substrate for this purpose. The Master-Cell-Bank and Working-Cell-Banks prepared by us are giving a practically inexhaustible cell source. Using micro-carrier culture, weekly more than 400 billion…

  92. 102.

    Dinparastisaleh R, Mirsaeidi M. · 2021 · PMID 33430064

    The melanocortin system encompasses melanocortin peptides, five receptors, and two endogenous antagonists. Besides pigmentary effects generated by α-Melanocytic Hormone (α-MSH), new physiologic roles in sexual activity, exocrine secretion, energy homeostasis, as well as immunomodulatory actions, exerted by melanocortins, have been described recently. Among the most common and burdensome consequences of chronic inflammation is the development of fibrosis. Depending on the regenerative capacity of…

  93. 103.

    Ge H, Zhang T, Tang Y, Zhang Y, Yu Y, Men F, Liu J, Yu Y. · 2022 · PMID 36362252

    Food-derived tripeptides can relieve colitis symptoms; however, their alleviation mode has not been systematically evaluated as an alternative nutritional compound. This study aimed to reveal the potential mechanism of 8000 food-derived tripeptides against acute colitis using a computer-aided screening strategy. Forty-one potential hub targets related to colitis with a Fit score > 4.0 were screened to construct the protein-protein and protein-tripeptide network based on the PharmMapper database…

  94. 104.

    Chen H, Sun J, Fang H, Lin Y, Wu H, Lin D, Yang Z, Zhou Q, Zhao B, Zhou T, Wu J, Li S, Liu X. · 2025 · PMID 41276472

    Food-derived bioactive peptides (FBPs), particularly those with ten or fewer amino acid residues and a molecular weight below 1300 Da, have gained increasing attention for their safe, diverse structures and specific biological activities. The development of FBP-based functional foods and potential medications depends on understanding their structure‒activity relationships (SARs), stability, and bioavailability properties. In this review, we provide an in-depth overview of the roles of FBPs in tr…

  95. 105.

    Singh M, Mukhopadhyay K. · 2014 · PMID 25140322

    The alpha-melanocyte stimulating hormone (α-MSH) is a neuropeptide belonging to the melanocortin family. It is well known for its anti-inflammatory and antipyretic effects and shares several characteristics with antimicrobial peptides (AMPs). There have been some recent reports about the direct antimicrobial activity of α-MSH against various microbes belonging to both fungal and bacterial pathogens. Similar to α-MSH's anti-inflammatory properties, its C-terminal residues also exhibit antimicrobi…

  96. 106.

    Bai JS, Kim RW, Li Y, Jung WK, et al. · Tissue & cell · 2026 · PMID 42854645

    Atherosclerosis develops through oxidative stress and inflammatory responses induced by oxidized low-density lipoprotein (oxLDL), and excessive lipid accumulation in macrophages accelerates disease progression by facilitating foam cell formation. In this study, we investigated the protective effects of the α-melanocyte-stimulating hormone-derived endogenous tripeptide Lysine-Proline-Valine (KPV) against oxLDL-induced cellular injury in RAW264.7 macrophages. Exposure to oxLDL markedly increased l…

  97. 107.

    An SH, Park JY, Lee SJ · Tissue & cell · 2026 · PMID 42585803

    Lysine-Proline-Valine (KPV), an endogenous tripeptide derived from α-melanocyte-stimulating hormone, has been recognized for its anti-inflammatory and antioxidant activities. However, its role in adipocyte differentiation has not been investigated. In this study, we investigated the regulatory effects of KPV on MDI-induced adipocyte differentiation in 3T3-L1 preadipocytes. KPV treatment dose-dependently suppressed adipocyte differentiation. Specifically, treatment with 100 μg/mL KPV reduced Oil…

Preprints (not yet peer-reviewed)

1
  1. 108.

    Khan II, Karshieva SS, Sokolova DV, Aidossov CM, Borisova YA, Bondarev NA, Kudryavtseva AA, Bazhenov SV, Manukhov IV, Pokrovsky VS. · 2025

    <h4>Purpose</h4> The emergence of new models of tumor growth requires a comparison of the results of the evaluation of the anticancer effect of single drug candidate for the selection of a relevant model. <h4>Methods</h4> We assessed the anticancer activity of the modified enzyme MGL-KPV using four models: 2D cultures, 3D spheroids, zebrafish embryo xenografts, and Balb/c nude mice. Cytotoxicity was tested in cancer cell lines and fibroblasts; efficacy was evaluated in zebrafish and mice. The ef…

Curated sources on file

1
  1. 1.

Continue reading